{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:09:24Z","timestamp":1791587364153,"version":"4.3.4"},"reference-count":39,"publisher":"PeerJ","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2017YFC1001904"],"award-info":[{"award-number":["2017YFC1001904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272447"],"award-info":[{"award-number":["82272447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Osteogenesis imperfecta (OI) is an inherited congenital disorder, characterized primarily by decreased bone mass and increased bone fragility. Bone morphogenetic protein-2 (BMP-2) is a potent cytokine capable of stimulating bone formation, however, its rapid degradation and unanticipated <jats:italic>in vivo<\/jats:italic> effects restrict its application. The sustained release characteristic of silk fibroin (SF) microspheres may potentially address the aforementioned challenges, nevertheless they have not previously been tested in OI treatment. In the current investigation, recombinant BMP-2 (rBMP-2) loaded SF (rBMP-2\/SF) microspheres-based release carriers were prepared by physical adsorption. The SF microparticles were characterized by scanning electron microscopy (SEM) and were investigated for their cytotoxicity behavior as well as the release profile of rBMP-2. The rBMP-2\/SF microspheres were administered via femoral intramedullary injection to two genotypes of OI-modeled mice daily for two weeks. The femoral microstructure and histological performance of OI mice were evaluated 2 weeks later. The findings suggested that rBMP-2\/SF spheres with a rough surface and excellent cytocompatibility demonstrated an initial rapid release within the first three days (22.15 \u00b1 2.88% of the loaded factor), followed by a transition to a slower and more consistent release rate, that persisted until the 15th day in an <jats:italic>in vitro<\/jats:italic> setting. The factor released from rBMP-2\/SF particles exhibited favorable osteoinductive activity. Infusion of rBMP-2\/SF microspheres, as opposed to blank SF spheres or rBMP-2 monotherapy, resulted in a noteworthy enhancement of femoral microstructure and promoted bone formation in OI-modeled mice. This research may offer a new therapeutic approach and insight into the management of OI. However, further investigation is required to determine the systematic safety and efficacy of rBMP-2\/SF microspheres therapy for OI.<\/jats:p>","DOI":"10.7717\/peerj.16191","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:17:46Z","timestamp":1698657466000},"page":"e16191","source":"Crossref","is-referenced-by-count":5,"title":["The recombinant BMP-2 loaded silk fibroin microspheres improved the bone phenotype of mild osteogenesis imperfecta mice"],"prefix":"10.7717","volume":"11","author":[{"given":"Ting","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4443","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"10.7717\/peerj.16191\/ref-1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bone.2007.12.215","article-title":"Role of genetic background in determining phenotypic severity throughout postnatal development and at peak bone mass in Col1a2 deficient mice (oim)","volume":"42","author":"Carleton","year":"2008","journal-title":"Bone"},{"key":"10.7717\/peerj.16191\/ref-2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1302\/1863-2548.13.190119","article-title":"Induction of periosteal bone formation by intraosseous BMP-2 injection in a mouse model of osteogenesis imperfecta","volume":"13","author":"Cheng","year":"2019","journal-title":"Journal of Childrens Orthopaedics"},{"key":"10.7717\/peerj.16191\/ref-3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00439-021-02302-2","article-title":"Collagen transport and related pathways in Osteogenesis Imperfecta","volume":"140","author":"Claeys","year":"2021","journal-title":"Human Genetics"},{"key":"10.7717\/peerj.16191\/ref-4","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00198-021-05933-3","article-title":"Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene","volume":"32","author":"Datta","year":"2021","journal-title":"Osteoporosis International"},{"key":"10.7717\/peerj.16191\/ref-5","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1021\/acsbiomaterials.1c00493","article-title":"Silk fibroin as a green material","volume":"7","author":"DeBari","year":"2021","journal-title":"ACS Biomaterials Science & Engineering"},{"key":"10.7717\/peerj.16191\/ref-6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.jconrel.2020.02.022","article-title":"Functionalized silk fibroin nanofibers as drug carriers: advantages and challenges","volume":"321","author":"Farokhi","year":"2020","journal-title":"Journal of Controlled Release"},{"key":"10.7717\/peerj.16191\/ref-7","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/jbmr.1592","article-title":"Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type I assessed by high-resolution pQCT","volume":"27","author":"Folkestad","year":"2012","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.7717\/peerj.16191\/ref-8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s10354-015-0368-3","article-title":"Classification of osteogenesis imperfecta","volume":"165","author":"Fratzl-Zelman","year":"2015","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.7717\/peerj.16191\/ref-9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-0716-3052-5_2","article-title":"The MTT assay: a method for error minimization and interpretation in measuring cytotoxicity and estimating cell viability","volume":"2644","author":"Ghasemi","year":"2023","journal-title":"Methods in Molecular Biology"},{"key":"10.7717\/peerj.16191\/ref-10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s11914-020-00594-3","article-title":"Stem cell therapy as a treatment for osteogenesis imperfecta","volume":"18","author":"Gotherstrom","year":"2020","journal-title":"Current Osteoporosis Reports"},{"key":"10.7717\/peerj.16191\/ref-11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.09.008","article-title":"Extracellular signaling molecules to promote fracture healing and bone regeneration","volume":"94","author":"Hankenson","year":"2015","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.7717\/peerj.16191\/ref-12","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.pcl.2014.08.010","article-title":"Update on the evaluation and treatment of osteogenesis imperfecta","volume":"61","author":"Harrington","year":"2014","journal-title":"Pediatric Clinics of North America"},{"key":"10.7717\/peerj.16191\/ref-13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/endrev\/bnab017","article-title":"Osteogenesis imperfecta: mechanisms and signaling pathways connecting classical and rare OI types","volume":"43","author":"Jovanovic","year":"2022","journal-title":"Endocrine Reviews"},{"issue":"9","key":"10.7717\/peerj.16191\/ref-14","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3390\/cells9092073","article-title":"Osteoblast-osteoclast communication and bone homeostasis","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"issue":"20","key":"10.7717\/peerj.16191\/ref-15","doi-asserted-by":"publisher","first-page":"7513","DOI":"10.3390\/ijms21207513","article-title":"Functions of osteocalcin in bone, pancreas, testis, and muscle","volume":"21","author":"Komori","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.7717\/peerj.16191\/ref-16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.addr.2012.09.043","article-title":"Silk fibroin biomaterials for tissue regenerations","volume":"65","author":"Kundu","year":"2013","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.7717\/peerj.16191\/ref-17","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.bioactmat.2020.10.018","article-title":"Synergistic anti-inflammatory and osteogenic n-HA\/resveratrol\/chitosan composite microspheres for osteoporotic bone regeneration","volume":"6","author":"Li","year":"2021","journal-title":"Bioactive Materials"},{"key":"10.7717\/peerj.16191\/ref-18","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1007\/s10637-022-01298-4","article-title":"BMP2 as a promising anticancer approach: functions and molecular mechanisms","volume":"40","author":"Li","year":"2022","journal-title":"Investigational New Drugs"},{"key":"10.7717\/peerj.16191\/ref-19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bone.2016.02.015","article-title":"Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate","volume":"87","author":"Lindahl","year":"2016","journal-title":"Bone"},{"key":"10.7717\/peerj.16191\/ref-20","doi-asserted-by":"publisher","first-page":"110235","DOI":"10.1016\/j.biopha.2020.110235","article-title":"The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment","volume":"128","author":"Liu","year":"2020","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.7717\/peerj.16191\/ref-21","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bone.2019.07.021","article-title":"A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I","volume":"127","author":"Liu","year":"2019","journal-title":"Bone"},{"key":"10.7717\/peerj.16191\/ref-22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/jbmr.4326","article-title":"Modification of COL1A1 in autologous adipose tissue-derived progenitor cells rescues the bone phenotype in a mouse model of osteogenesis imperfecta","volume":"36","author":"Liu","year":"2021","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.7717\/peerj.16191\/ref-23","doi-asserted-by":"publisher","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"key":"10.7717\/peerj.16191\/ref-24","article-title":"Osteogenesis imperfecta","author":"Marini","year":"2000","journal-title":"Endotext"},{"key":"10.7717\/peerj.16191\/ref-25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ajmg.c.31532","article-title":"Pharmacological and biological therapeutic strategies for osteogenesis imperfecta","volume":"172","author":"Marom","year":"2016","journal-title":"American Journal of Medical Genetics Part C: Seminars in Medical Genetics"},{"key":"10.7717\/peerj.16191\/ref-26","doi-asserted-by":"publisher","first-page":"R95","DOI":"10.1530\/EJE-20-0299","article-title":"Osteogenesis imperfecta: an update on clinical features and therapies","volume":"183","author":"Marom","year":"2020","journal-title":"European Journal of Endocrinology"},{"key":"10.7717\/peerj.16191\/ref-27","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.matbio.2018.03.010","article-title":"Osteogenesis imperfecta and therapeutics","volume":"71-72","author":"Morello","year":"2018","journal-title":"Matrix Biology"},{"key":"10.7717\/peerj.16191\/ref-28","doi-asserted-by":"publisher","first-page":"115703","DOI":"10.1016\/j.bone.2020.115703","article-title":"Widespread disturbance in extracellular matrix collagen biomarker responses to teriparatide therapy in osteogenesis imperfecta","volume":"142","author":"Nicol","year":"2021","journal-title":"Bone"},{"key":"10.7717\/peerj.16191\/ref-29","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.addr.2010.03.009","article-title":"Silk-based delivery systems of bioactive molecules","volume":"62","author":"Numata","year":"2010","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.7717\/peerj.16191\/ref-30","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/jor.25414","article-title":"Modeling anabolic and antiresorptive therapies for fracture healing in a mouse model of osteogenesis imperfecta","volume":"41","author":"O\u2019Donohue","year":"2022","journal-title":"Journal of Orthopaedic Research"},{"key":"10.7717\/peerj.16191\/ref-31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/MOP.0000000000000813","article-title":"Osteogenesis imperfecta: advancements in genetics and treatment","volume":"31","author":"Rossi","year":"2019","journal-title":"Current Opinion in Pediatrics"},{"key":"10.7717\/peerj.16191\/ref-32","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/s8756-3282(96)00305-5","article-title":"Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta","volume":"19","author":"Saban","year":"1996","journal-title":"Bone"},{"key":"10.7717\/peerj.16191\/ref-33","doi-asserted-by":"publisher","first-page":"110480","DOI":"10.1016\/j.msec.2019.110480","article-title":"Porous calcium phosphate-collagen composite microspheres for effective growth factor delivery and bone tissue regeneration","volume":"109","author":"Seong","year":"2020","journal-title":"Materials Science & Engineering C-Materials for Biological Applications"},{"key":"10.7717\/peerj.16191\/ref-34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/00037028211055477","article-title":"Infrared spectroscopy-determined bone compositional changes associated with anti-resorptive treatment of the oim\/oim mouse model of osteogenesis imperfecta","volume":"76","author":"Shanas","year":"2022","journal-title":"Applied Spectroscopy"},{"key":"10.7717\/peerj.16191\/ref-35","first-page":"113","article-title":"Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity","volume":"15","author":"Sillence","year":"1979","journal-title":"Birth Defects Original Article Series"},{"key":"10.7717\/peerj.16191\/ref-36","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00198-014-2737-y","article-title":"Adult Brtl\/+ mouse model of osteogenesis imperfecta demonstrates anabolic response to sclerostin antibody treatment with increased bone mass and strength","volume":"25","author":"Sinder","year":"2014","journal-title":"Osteoporosis International"},{"key":"10.7717\/peerj.16191\/ref-37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jbmr.3617","article-title":"Effect of anti-TGF- \u03b2 treatment in a mouse model of severe osteogenesis imperfecta","volume":"34","author":"Tauer","year":"2019","journal-title":"Journal of Bone and Mineral Research"},{"issue":"3","key":"10.7717\/peerj.16191\/ref-38","doi-asserted-by":"publisher","first-page":"035012","DOI":"10.1088\/1748-605X\/ac65cc","article-title":"Developing a novel calcium magnesium silicate\/graphene oxide incorporated silk fibroin porous scaffold with enhanced osteogenesis, angiogenesis and inhibited osteoclastogenesis","volume":"17","author":"Wu","year":"2022","journal-title":"Biomedical Materials"},{"key":"10.7717\/peerj.16191\/ref-39","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijbiomac.2019.08.139","article-title":"Drugs adsorption and release behavior of collagen\/bacterial cellulose porous microspheres","volume":"140","author":"Zhang","year":"2019","journal-title":"International Journal of Biological Macromolecules"}],"container-title":["PeerJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/peerj.com\/articles\/16191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16191.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16191.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/peerj.com\/articles\/16191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:18:03Z","timestamp":1698657483000},"score":1,"resource":{"primary":{"URL":"https:\/\/peerj.com\/articles\/16191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":39,"alternative-id":["10.7717\/peerj.16191"],"URL":"https:\/\/doi.org\/10.7717\/peerj.16191","archive":["CLOCKSS","LOCKSS","Portico"],"relation":{},"ISSN":["2167-8359"],"issn-type":[{"value":"2167-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]},"article-number":"e16191"}}